| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/03/2003 | US20030064427 Monitor and evaluating sterilization proces; obtain indicator, sterliize, monitor release of dipicolinic acid, presence of dipicolinic acid indicates sterlization |
| 04/03/2003 | US20030064426 Expression vector for use in the treatment of cancer and age-related defects |
| 04/03/2003 | US20030064425 Microfluidic in-line labeling method for continuous-flow protease inhibition analysis |
| 04/03/2003 | US20030064424 Diagnostic test kit for detecting transmissible spongiform encephalopathies |
| 04/03/2003 | US20030064421 Methods for treating a patient with neoplasia by administering cGMP-specific PDE-inhibiting compounds |
| 04/03/2003 | US20030064415 Propagation of cells; prepare nutrient broth, inoculate broth with cells, propagate cells, evaluate cells |
| 04/03/2003 | US20030064414 Rapid assessment of coagulation activity in whole blood |
| 04/03/2003 | US20030064407 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064403 Multiplex protein interaction determinations using glutathione-GST binding |
| 04/03/2003 | US20030064402 Probes for use in the hybridization and detection of preferential nucleotide sequences; for use in forensic medicine |
| 04/03/2003 | US20030064401 Diagnosing psychological disorders in humans; obtain tissue sample humans, test sample for presence of polymorphism in promoter of nerve growth factor, presence of polymorphism indicates psychological disorder |
| 04/03/2003 | US20030064400 Apparatus for use in the analysis of nucleotide sequences |
| 04/03/2003 | US20030064395 Cleaving target nucleic acid with chimeric endonuclease; provide cells containg target sequences, incubate with endonuclease, recover cleaved nucleic acids |
| 04/03/2003 | US20030064394 Kit for use in the regeneration of adenosine triphosphate |
| 04/03/2003 | US20030064393 Integrated systems and methods for diversity generation and screening |
| 04/03/2003 | US20030064392 Humanizing plant nucleotide sequences; obtain human nucleotide sequences, insert into viral vector, infect cell, propagate cell, detect phenotypic adjustment, sequence insert, compare plant and human sequences |
| 04/03/2003 | US20030064391 Preparation of sequences on substrate; obtain substrate, deposit on plate surface, incubate with activator, remove protective groups, recover biopolymer |
| 04/03/2003 | US20030064390 Detection and measurement of biopolymer in solution; obtain sample comtining biopolymer, incubate with binding agent, measure electrical conductivity generate from bound complex, quantify complex |
| 04/03/2003 | US20030064388 Oligonucleotides for detecting bacteria and detection process |
| 04/03/2003 | US20030064386 Probe array for detecting a target material using stereo-substrate |
| 04/03/2003 | US20030064385 Genes expressed in breast cancer as prognostic and therapeutic targets |
| 04/03/2003 | US20030064384 Beta-catenin is a strong and independent prognostic factor for cancer |
| 04/03/2003 | US20030064383 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer |
| 04/03/2003 | US20030064382 Probes for use in the sequencing of preferential nucleotide sequences |
| 04/03/2003 | US20030064381 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer, nervous system, sexual, urogenital, viral and cushing's disease |
| 04/03/2003 | US20030064377 Compositions and methods relating to prostate specific genes and proteins |
| 04/03/2003 | US20030064376 Genome walking by selective amplification of nick-translate DNA library and amplification from complex mixtures of templates |
| 04/03/2003 | US20030064375 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of kidney, nervous system and arthritic disorders |
| 04/03/2003 | US20030064374 Detecting neuronal stress in humans; obtain sample, measure phosphodiesterase concentration, evaluate for neuronal stress |
| 04/03/2003 | US20030064373 Preferential display |
| 04/03/2003 | US20030064372 Gene and sequence variation associated with lipid disorder |
| 04/03/2003 | US20030064371 Method for detecting cell proliferative disorders |
| 04/03/2003 | US20030064370 Nucleic acid promoters |
| 04/03/2003 | US20030064369 Novel proteins and nucleic acids encoding same |
| 04/03/2003 | US20030064368 Methods, apparatus, and computer programs for verifying the integrity of a probe |
| 04/03/2003 | US20030064367 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064366 Real-time sequence determination |
| 04/03/2003 | US20030064365 Gap vector for E. coli stop codon assay and method for detecting heterozygous mutation using the same |
| 04/03/2003 | US20030064364 Nucleic acid analysis techniques |
| 04/03/2003 | US20030064363 Gene encoding a new TRP channel is mutated in mucolipidosis IV |
| 04/03/2003 | US20030064362 Detecting bacterium, pollen, virus, prion and metabolic toxin in fluids; obtain sample, incubate with macrophage, monitor for resence of impurities and toxic substances |
| 04/03/2003 | US20030064358 Screening modulators of contractile force and tissue stiffness in cells; obtain cells, incubate with modulator, monitor contractile activity and stiffness in cells |
| 04/03/2003 | US20030064316 Solvent resistant photosensitive compositions |
| 04/03/2003 | US20030064054 Detection of human immunodeficiency virus using cells transduced with a complex viral vector |
| 04/03/2003 | US20030063281 Inspection device for body to be inspected and inspection device of foreign matters in liquid filled in transparent container |
| 04/03/2003 | US20030063112 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030062263 Sensors with variable response behavior |
| 04/03/2003 | US20030061687 Simultaneously introducing target solution at a known concentration into the chambers of a microfluidic device; solvent concentration is varied in each of the chambers to provide a large number of crystallization environments |
| 04/03/2003 | CA2820170A1 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/03/2003 | CA2820144A1 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/03/2003 | CA2462139A1 Stem-loop vector system |
| 04/03/2003 | CA2461864A1 Biological discovery using gene regulatory networks generated from multiple-disruption expression libraries |
| 04/03/2003 | CA2461861A1 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 04/03/2003 | CA2461532A1 Use of isogenic human cancer cells for high-throughput screening and drug discovery |
| 04/03/2003 | CA2461526A1 Aptamers containing sequences of nucleic acids or nucleic acid analogues bound homologously, or in novel complexes |
| 04/03/2003 | CA2461454A1 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior |
| 04/03/2003 | CA2461376A1 Nucleic acids for the identification of fungi and methods for using the same |
| 04/03/2003 | CA2461372A1 Dna sequences for human angiogenesis genes |
| 04/03/2003 | CA2461305A1 Methods of suppressing microglial activation and systemic inflammatory responses |
| 04/03/2003 | CA2461271A1 Systems, methods and kits for remote genetic analysis and consultation |
| 04/03/2003 | CA2461139A1 Method for producing a normalized gene library from nucleic acid extracts of soil samples and the use thereof |
| 04/03/2003 | CA2461019A1 Stabilization of t4 endonuclease v |
| 04/03/2003 | CA2460953A1 Proteins associated with cell growth, differentiation, and death |
| 04/03/2003 | CA2460575A1 Enzymatic conversion of blood group a, b, and ab red blood cells using .alpha.-n-acetylgalactosaminidases and .alpha.-galactosidases with unique substrate specificities and kinetic properties |
| 04/03/2003 | CA2459926A1 Screening and selection methods for statin drug combinations |
| 04/03/2003 | CA2459827A1 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/03/2003 | CA2459807A1 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/03/2003 | CA2455117A1 Enzyme phosphorylating ser46 of p53 |
| 04/03/2003 | CA2453985A1 Receptors and membrane-associated proteins |
| 04/03/2003 | CA2414570A1 Method, system, and knowledge repository for identifying a secondary metabolite from a microorganism |
| 04/02/2003 | EP1298572A2 Method for analyzing trait map |
| 04/02/2003 | EP1298437A1 Colorimetric test device with reduced error |
| 04/02/2003 | EP1298428A1 Device for inspecting liquid-filled transparent containers |
| 04/02/2003 | EP1298223A2 Methods related to the A-C repeat Z-sequence upstream from the aldose reductase gene |
| 04/02/2003 | EP1298222A2 Methods to evaluate rice palatability and to select rice with platable traits through analysis of half grain of unhulled/unpulische rice |
| 04/02/2003 | EP1298221A1 Means and methods for treatment evaluation |
| 04/02/2003 | EP1298220A1 Single nucleotide polymorphisms predicting cardiovascular disease |
| 04/02/2003 | EP1298211A2 Polynucleotide segment of HPV16 Genome |
| 04/02/2003 | EP1298208A2 Ribozymes targeting a hiv tat sequence |
| 04/02/2003 | EP1298203A2 Diagnosis and treatment of autoimmune diseases |
| 04/02/2003 | EP1297484A2 Method and apparatus for sequence analysis |
| 04/02/2003 | EP1297482A2 Algorithmic determination of flanking dna sequences that control the expression of sets of genes in prokaryotic, archea and eukaryotic genomes |
| 04/02/2003 | EP1297341A2 Methods of identifying gaba b? receptor subtype-specific agonists |
| 04/02/2003 | EP1297338A2 Microarrays for performing proteomic analyses |
| 04/02/2003 | EP1297337A2 Method for increasing luminescence assay sensitivity |
| 04/02/2003 | EP1297335A2 Process for the measurement of dinophysistoxin and of yessotoxin |
| 04/02/2003 | EP1297187A2 Method for the detection of influenza a/b viruses |
| 04/02/2003 | EP1297186A1 Method of screening for chemotherapeutic treatments for cancer |
| 04/02/2003 | EP1297185A2 Diagnosis of diseases associated with signal transduction |
| 04/02/2003 | EP1297184A1 Method for monitoring the effect of cancer therapies |
| 04/02/2003 | EP1297182A2 Diagnosis of diseases associated with cell signalling |
| 04/02/2003 | EP1297181A2 Sample generation for genotyping by mass spectrometry |
| 04/02/2003 | EP1297180A2 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| 04/02/2003 | EP1297179A1 Detection of nucleic acid hybridization by fluorescence polarization |
| 04/02/2003 | EP1297178A2 Real time monitoring of pcr using loci ("luminescent oxygen channeling immunoassay technology") |
| 04/02/2003 | EP1297177A1 Vibrio bacteria detection and/or differentiation |
| 04/02/2003 | EP1297176A1 Micro-organisms with glycosylation modulating action of intestinal cell surface |
| 04/02/2003 | EP1297167A1 Tumour-cell specific gene expression and its use in cancer therapy |
| 04/02/2003 | EP1297163A2 Recombinant constructs and their use in reducing gene expression |
| 04/02/2003 | EP1297152A2 Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof |